Q32 Bio Inc (QTTB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $248.07M
Last updated: Nov 17, 2026 at 4:15 PM ET
Q32 Bio Inc (QTTB) Stock Chart
Q32 Bio (QTTB) has a latest price of $8.63 on Nov 17, 2026, 63.4% below its 52-week high of $23.57. Its price rose 299.5% over the past 12 months. The month-end price fell 97.4% since Mar 2018, a compound annual decline of 34.5%.
Price Chart
From Mar 2018 to Oct 2026, its highest month-end close was $530.22 in Feb 2019 and its lowest $1.49 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart QTTB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for QTTB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 45.5%, and over 6 months it rose 42.2%. The month-end price fell 52.4% over the 3 years through Oct 2026, a compound annual decline of 21.9%.
| Period | Change |
|---|---|
| 1 month | +10.8% |
| 3 months | -45.5% |
| 6 months | +42.2% |
| 12 months | +299.5% |
| 12 months, with dividends | +299.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -52.4% | -21.9% |
| 5 years | -91.4% | -38.7% |
| Since Mar 2018 | -97.4% | -34.5% |
Price by Year
Its best calendar year was 2025, when the price fell 3.5%, and its weakest was 2024, when it fell 68.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.91 | +168.4% |
| 2025 | $3.32 | -3.5% |
| 2024 | $3.44 | -68.5% |
| 2023 | $10.94 | -51.7% |
| 2022 | $22.66 | -65.4% |
| 2021 | $65.47 | -67.8% |
| 2020 | $203.06 | -45.5% |
| 2019 | $372.30 | -7.4% |
Trading Range
The price is 4.9% below its 50-day average of $9.08 and 9.5% below its 200-day average of $9.53.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.63 | |
| 52-week high | $23.57 | -63.4% |
| 52-week low | $1.91 | +353.0% |
| 50-day average | $9.08 | -4.9% |
| 200-day average | $9.53 | -9.5% |
Price Risk
Over 3 years, its largest fall from a peak was 97.3%.
| Measure | Value |
|---|---|
| 1-year beta | 0.07 |
| Largest fall, 1 year | -64.8% |
| Largest fall, 3 years | -97.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About QTTB
What is QTTB's 1-year price change?
Q32 Bio's price rose 299.5% over the past 12 months. With dividends included, the 12-month total return was 299.5%.
What is QTTB's 5-year price change?
Q32 Bio's month-end price fell 91.4% over the 5 years through Oct 2026, a compound annual decline of 38.7%. These figures leave out dividends.
What is QTTB's 52-week high and low?
Q32 Bio's 52-week high is $23.57 and its 52-week low is $1.91. Its latest price of $8.63 on Nov 17, 2026 is 63.4% below the high.
What is QTTB's beta?
Q32 Bio's 1-year beta against the S&P 500 is 0.07, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 64.8%.
Is the QTTB chart free?
Yes. Advanced Charting for QTTB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
QTTB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors